Purchase Order HHSF223201510571A
Award Date 9/12/15
Potential Completion Date 10/14/15
Potential Value $84K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $505,454 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of advanced DNA sequencing systems and reagents. The contract is for the delivery of a "REAL TIME DNA SEQUENCER" and is set aside for small business. Pacific Biosciences specializes in their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal...
- The U.S. Food and Drug Administration awarded a $736,000 firm fixed-price definitive contract to Pacific Biosciences of California, Inc. for a real-time sequencer system with four one-year post-warranty maintenance option periods. The contract, awarded on September 3, 2019, with an ultimate completion date of December 11, 2024, is designated as a Total Small Business set-aside. Pacific Biosciences, a leading biotechnology company specializing in advanced DNA and RNA sequencing technologies, will...
- Pacific Biosciences of California, Inc., a small business biotechnology firm specializing in long-read DNA and RNA sequencing technologies, received a $726,318.04 firm fixed-price purchase order from the Food and Drug Administration on September 28, 2023. The award covers a Sequel IIE long-read DNA/RNA sequencer system and associated consumables to support the National Antimicrobial Resistance Monitoring System. The contract, designated as a total small business set-aside, includes performance...
- This federal contract award to Pacific Biosciences of California, Inc. (PacBio) provides for the delivery of a PacBio RS DNA sequencing system with a 12-month service contract. The $998,000.00 firm fixed price contract was awarded by the Food and Drug Administration (FDA), a civilian agency, without the use of a set-aside. PacBio is the original equipment manufacturer for the PacBio Sequel and Sequel II sequencing platforms, which are in high demand across federal agencies for genomic research...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of a single molecule, real-time (SMRT) long-read DNA sequencer and associated installation, training, and shipping services. The total potential value of the contract is $397,500. This procurement was conducted as a full and open competition, with no set-aside designation. Pacific Biosciences is an established provider of specialized sequencing equipment and consumables to various U.S. government agencies,...
- The U.S. Food and Drug Administration (FDA) has awarded a $39,657.00 firm fixed-price delivery order to Pacific Biosciences of California, Inc. (PacBio) under the company's existing $1 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the agency. This delivery order is for the purchase of specific supplies and reagents to support the agency's use of PacBio's Sequel IIe long-read DNA/RNA sequencing platform. The award, made without a set-aside designation, is the latest task...
- This is a purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. The contract is for $138,848.00 and is a firm fixed price agreement. The contract provides Pacific Biosciences, a manufacturer of scientific equipment, reagents, and services, the opportunity to deliver their proprietary Sequel and Sequel II DNA/RNA sequencing systems, along with associated consumables and software, to...
- The Food and Drug Administration (FDA) awarded a $336,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. on August 21, 2015, for Part Number 100-236-400, a standard PacBio service contract with a base period and four option years. The contract was completed on July 22, 2019, with performance undertaken at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a leading biotechnology company...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...